Nj State Employees Deferred Compensation Plan Bristol Myers Squibb CO Transaction History
Nj State Employees Deferred Compensation Plan
- $824 Million
- Q3 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 43,884 shares of BMY stock, worth $2.58 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
43,884
Previous 43,884
-0.0%
Holding current value
$2.58 Million
Previous $1.82 Million
24.59%
% of portfolio
0.28%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,533Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.34 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.47 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.59 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.59 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...